Výsledky vyhledávání - "Haruo, Nishino"

Akademický článek

Comparison of efficacies of once-daily dose multimatrix mesalazine and multiple-dose mesalazine for the maintenance of remission in ulcerative colitis: a randomized, double-blind study

Autor: Haruhiko Ogata, Akihiro Ohori, Haruo Nishino, Seiichi Mizushima, Atsushi Hagino, Toshifumi Hibi

Publikováno v: Intestinal Research, Vol 15, Iss 3, Pp 358-367 (2017)

Background/Aims: This study compared the efficacy of once-daily administration of multimatrix mesalazine 2.4 g/day with multiple-dose mesalazine for the maintenance of remission.Methods: In this multicenter, randomized, double-blind study, 203 patien

Externí odkaz: https://doaj.org/article/f4a2d13947bf4559b2b006ae761b0887

Zobrazit plný text záznamu

Reducing adenoma miss rate of colonoscopy assisted by artificial intelligence: a multicenter randomized controlled trial

Autor: Akihiro Fukuda, Yuki Shimahara, Iduru Saitoh, Taku Sakamoto, Naoto Tamai, Shunsuke Kamba, Hiroaki Matsui, Masako Nishikawa, Haruo Nishino, Aya Tonouchi, Hideka Horiuchi, Masakuni Kobayashi, Kazuki Sumiyama, Mai Ego, Yutaka Saito

Publikováno v: Journal of Gastroenterology. 56:746-757

We have developed the computer-aided detection (CADe) system using an original deep learning algorithm based on a convolutional neural network for assisting endoscopists in detecting colorectal lesions during colonoscopy. The aim of this study was to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf826c9fdff470b0fd5467c8ef51fe03
https://doi.org/10.1007/s00535-021-01808-w

Zobrazit plný text záznamu

Impact of Artificial Intelligence on Colonoscopy Surveillance After Polyp Removal: A Pooled Analysis of Randomized Trials

Publikováno v: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Artificial intelligence (AI) tools aimed at improving polyp detection have been shown to increase the adenoma detection rate during colonoscopy. However, it is unknown how increased polyp detection rates by AI affect the burden of patient surveillanc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e574a8660cfe7f080b83a6ea85c733e
https://pubmed.ncbi.nlm.nih.gov/36038128

Zobrazit plný text záznamu

2.4 g Mesalamine (Asacol 400 mg tablet) Once Daily is as Effective as Three Times Daily in Maintenance of Remission in Ulcerative Colitis

Autor: Mitsuo Iida, Yasuo Suzuki, Toshifumi Hibi, Haruo Nishino, Takanori Okubo, Hiroaki Ito, Toshihide Ohmori, Tadashi Yokoyama, Takehiro Arai

Publikováno v: Inflammatory Bowel Diseases

Article first Published online 31 March 2017
Background: The noninferiority of pH-dependent release mesalamine (Asacol) once daily (QD) to 3 times daily (TID) administration was investigated. Methods: This was a phase 3, multicenter, randomized,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1592827e2d6e7112ba1d31b77b19d5ba
https://doi.org/10.1097/mib.0000000000001065

Zobrazit plný text záznamu

[A case of Crohn's disease complicated by Guillain-Barrè syndrome during ustekinumab therapy]

Autor: Tsuneo, Fukushima, Kouichi, Nakajima, Hiroshi, Nozawa, Haruo, Nishino, Akira, Sugita, Kazutaka, Koganei, Ryou, Futatsuki, Shigeki, Yamaguchi, Shiori, Asano, Makoto, Matsushima

Publikováno v: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology. 116(4)

We herein report a case involving a 23-year-old male patient with active Crohn's disease complicated by Guillain-Barrè syndrome during ustekinumab therapy. At age 11, the patient developed an anal fistula and was found to have multiple aphthae on th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::843714abafbe4236e26067e5442d42bc
https://pubmed.ncbi.nlm.nih.gov/30971669

Zobrazit plný text záznamu

Factors associated with poor therapeutic response in outpatients with irritable bowel syndrome: a multicenter study in Japan

Autor: Seitaro Watanabe, Masataka Tagri, Kazuki Nagai, Eiji Yamada, Hiromichi Teraoka, Ichiro Kawana, Seishi Tsunoda, Eri Uchida, Noriomi Hosaka, Atsushi Nakajima, Haruo Nishino, Tsuyoshi Abe

Publikováno v: Journal of Gastroenterology. 52:301-307

Some patients with irritable bowel syndrome (IBS) show poor response to treatment. However, risk factors associated with poor therapeutic response have not been determined. This multicenter trial evaluated consecutive outpatients with IBS undergoing

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a0f91a353e4469f5591ca93175e76fb
https://doi.org/10.1007/s00535-016-1215-z

Zobrazit plný text záznamu

Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis

Autor: Kiyonori Kobayashi, Yasuo Suzuki, Toshifumi Hibi, Fumihito Hirai, Nobuo Aoyama, Haruo Nishino, Makoto Naganuma, Kenji Watanabe

Publikováno v: Journal of Crohn's & Colitis

Background and Aims: Mucosal healing is an important therapeutic goal for ulcerative colitis. Once-daily administration of budesonide 2-mg foam is widely used for inducing clinical remission. No study has assessed the usefulness of twice-daily budeso

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b426b7ac02c1d7cbbf621899e5a719d
https://doi.org/10.1093/ecco-jcc/jjv208

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání